(Q45949305)

English

Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response.

scientific article published in February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

environmental stressor

1 reference

based on heuristic

inferred from title

Gavin P. Reynolds

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

author name string

Mengjia Pu

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Zhijun Zhang

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Zhi Xu

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Yanyan Shi

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Leiyu Geng

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Yonggui Yuan

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Xiangrong Zhang

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

publication date

1 February 2013

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Pharmacogenomics

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

14

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

277-288

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Pharmacogenomics of antidepressant drugs

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

The role of glutamate on the action of antidepressants

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Pharmacogenomics with antidepressants in the STAR*D study

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Vulnerability to depression: what is the role of stress genes in gene x environment interaction?

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

The role of pharmacogenetics in the treatment of depression and anxiety disorders

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

The GABAergic deficit hypothesis of major depressive disorder.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Pharmacogenomics of psychiatric disorders

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Mood disorders: regulation by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

New therapeutic targets for mood disorders

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Glutamatergic modulators: the future of treating mood disorders?

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Pedigree disequilibrium tests for multilocus haplotypes.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Evidence of association between gamma-aminobutyric acid type A receptor genes located on 5q34 and female patients with mood disorders

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

A novel class of GABAA receptor subunit in tissues of the reproductive system

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Neurosteroids and GABAA receptor function.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Whole genome linkage scan of recurrent depressive disorder from the depression network study.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Overexpression of the GABA(A) receptor epsilon subunit results in insensitivity to anaesthetics

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Functional implications of neurotransmitter co-release: glutamate and GABA share the load

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Sustained structural change of GABA(A) receptor-associated protein underlies long-term potentiation at inhibitory synapses on a cerebellar Purkinje neuron.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Interaction between SERTPR and stressful life events on response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Stress and the brain: from adaptation to disease

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Chronic and acute stress, gender, and serotonin transporter gene-environment interactions predicting depression symptoms in youth

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

A validation study of the Dutch Childhood Trauma Questionnaire-Short Form: Factor structure, reliability, and known-groups validity

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.1

21 January 2018

Identifiers

10.2217/PGS.13.1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23394390

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45949305&oldid=1970790021"